These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25549186)

  • 1. Rational design and engineering of a modified adeno-associated virus (AAV1)-based vector system for enhanced retrograde gene delivery.
    Davis AS; Federici T; Ray WC; Boulis NM; OʼConnor D; Clark KR; Bartlett JS
    Neurosurgery; 2015 Feb; 76(2):216-25; discussion 225. PubMed ID: 25549186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
    Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
    J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
    Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
    Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism.
    Powell SK; Khan N; Parker CL; Samulski RJ; Matsushima G; Gray SJ; McCown TJ
    Gene Ther; 2016 Nov; 23(11):807-814. PubMed ID: 27628693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells.
    Zhang L; Rossi A; Lange L; Meumann N; Koitzsch U; Christie K; Nesbit MA; Moore CBT; Hacker UT; Morgan M; Hoffmann D; Zengel J; Carette JE; Schambach A; Salvetti A; Odenthal M; Büning H
    Hum Gene Ther; 2019 Oct; 30(10):1284-1296. PubMed ID: 31407607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses.
    Albright BH; Simon KE; Pillai M; Devlin GW; Asokan A
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of tissue tropism determinants of adeno-associated virus type 1.
    Hauck B; Xiao W
    J Virol; 2003 Feb; 77(4):2768-74. PubMed ID: 12552020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
    Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
    J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
    Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
    Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells.
    Stachler MD; Bartlett JS
    Gene Ther; 2006 Jun; 13(11):926-31. PubMed ID: 16482202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomic structure of a rationally engineered gene delivery vector, AAV2.5.
    Burg M; Rosebrough C; Drouin LM; Bennett A; Mietzsch M; Chipman P; McKenna R; Sousa D; Potter M; Byrne B; Jude Samulski R; Agbandje-McKenna M
    J Struct Biol; 2018 Sep; 203(3):236-241. PubMed ID: 29775653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
    Dayton RD; Grames MS; Klein RL
    Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury.
    Petrosyan HA; Alessi V; Singh V; Hunanyan AS; Levine JM; Arvanian VL
    Gene Ther; 2014 Dec; 21(12):991-1000. PubMed ID: 25119378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient retrograde neuronal transduction utilizing self-complementary AAV1.
    Hollis ER; Kadoya K; Hirsch M; Samulski RJ; Tuszynski MH
    Mol Ther; 2008 Feb; 16(2):296-301. PubMed ID: 18223548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector.
    Hutson TH; Verhaagen J; Yáñez-Muñoz RJ; Moon LD
    Gene Ther; 2012 Jan; 19(1):49-60. PubMed ID: 21562590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression.
    Zhou X; Liu J; Xiao S; Liang X; Li Y; Mo F; Xin X; Yang Y; Gao C
    Int J Nanomedicine; 2024; 19():7691-7708. PubMed ID: 39099791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of adeno-associated viral vector-mediated gene delivery to the hypothalamus.
    de Backer MW; Brans MA; Luijendijk MC; Garner KM; Adan RA
    Hum Gene Ther; 2010 Jun; 21(6):673-82. PubMed ID: 20073991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.